🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is being done to find out whether tisotumab vedotin works better...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2021-02-22
Trial ID
NCT04697628
Treatments Being Tested
This is an open label, multi-center trial of tisotumab vedotin monotherapy ...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2019-02-27
Trial ID
NCT03786081
Treatments Being Tested
This is an open-label, single arm, phase 2 study designed to evaluate the e...
Status
Not Yet Recruiting
Location
Atrium Health Levine Cancer Center
Start Date
2026-11
Trial ID
NCT07672782
Treatments Being Tested
TIVDAK is used for the treatment of cervical cancer that has come back afte...
Status
Recruiting
Location
HonorHealth Cancer Care - Biltmore - AZCCC Imaging
Start Date
2025-05-07
Trial ID
NCT06952660
Treatments Being Tested
This trial will study tisotumab vedotin to find out what its side effects a...
Status
Completed
Location
Stanford Cancer Center South Bay
Start Date
2019-03-20
Trial ID
NCT03657043
Treatments Being Tested
This trial will study tisotumab vedotin to find out whether it is an effect...
Status
Active Not Recruiting
Location
UCSD Medical Center - Encinitas
Start Date
2018-06-25
Trial ID
NCT03485209
Treatments Being Tested
The purpose of the trial is to establish the tolerability of HuMax-TF-ADC i...
Status
Completed
Location
University of California Irvine Medical Center (UCIMC)
Start Date
2013-11-30
Trial ID
NCT02001623
Treatments Being Tested
The purpose of the trial is to evaluate efficacy and safety of continued tr...
Status
Completed
Location
Brian Slomovitz
Start Date
2017-08-23
Trial ID
NCT03245736
Treatments Being Tested
A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®...
Status
Completed
Location
University of Alabama
Start Date
2018-06-12
Trial ID
NCT03438396
Treatments Being Tested